查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676707

GMP 級細胞培養基市場按成分、產品類型、細胞培養類型、細胞類型和應用分類 - 2025-2030 年全球預測

GMP Grade Cell Culture Media Market by Component, Product Type, Cell Culture Type, Cell Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

GMP 級細胞培養基市場預計在 2024 年價值為 79.3 億美元，到 2025 年以 9.99% 的複合年成長率成長至 87.1 億美元，到 2030 年將達到 140.6 億美元。

主要市場統計數據
基準年 2024 年 79.3億美元
預計 2025 年 87.1億美元
預測年份 2030 140.6億美元
複合年成長率（%） 9.99％

GMP級細胞培養基是生物製藥開發和科學研究進步的基石。在當今快速發展的生物技術環境中，嚴格的品質標準和對監管要求的遵守推動這些高等級培養基的作用。隨著對產品製造一致性的需求不斷增加以及對整體製程可靠性的相關影響，相關人員認知到 GMP 級介質是確保安全性和效能結果的關鍵要素。

實現這些標準不僅僅是滿足監管清單的問題；它需要研究創新、流程最佳化和強大的品管的持續相互作用。在過去的十年中，對先進配方和技術創新的投資推動了 GMP 級培養基的發展。本介紹對直接影響市場動態的市場趨勢和關鍵細分見解進行了全面的分析。我們將強調培養基品質所起的關鍵作用，討論這些產品如何成為現代生物加工領域的重要組成部分，幫助減少廣泛說明範圍內的變異性並提高可重複性。

高等級細胞培養基的重要性也反映在組織工程、基因治療和重組蛋白生產的精簡通訊協定中。透過樹立行業標桿，這些媒體不僅確保符合國際品質標準，而且還促進了推動整個產業發展的尖端研究。

此外，隨著公司不斷最佳化生產流程，對GMP級培養基的策略性投資已成為其研發工作的關鍵方面。本介紹為市場的多方面發展提供了清晰的背景，並強調了細胞培養應用領域的法律規範、技術創新和市場需求動態之間的內在聯繫。

景觀的變革

在生物技術的快速進步、監管環境的不斷演變和全球對創新的關注的推動下，細胞培養基領域經歷了變革性的轉變。近年來，新技術的融合和不斷發展的科學通訊協定重新定義了該行業。流程自動化、改進的分析技術和更緊密的即時監控系統整合都有助於提高細胞培養流程的操作流程和可重複性。

值得注意的是，隨著監管機構完善其指導方針以更好地確保產品的安全性和有效性，製造商必須重新調整其生產方法。這種轉變正在刺激下一代 GMP 級細胞培養基的開發，以滿足大規模生物製藥製造和複雜研究應用不斷變化的需求。對品質和一致性的日益重視促使公司投入研究，從而開發出適合不同細胞類型和應用的培養基配方。

此外，全球合作與夥伴關係促進了生產設施之間的技術轉移和標準化。因此，以前較慢採用尖端細胞培養方法的地區現在正在迅速趕上。這種轉變不僅體現在產品創新上，也體現在如何產生、分析和利用流程資料來推動持續改進。現代製造技術正在促進以更具活力、更注重結果的方式來應對挑戰，使技術能力與當今市場患者的高期望相結合。

先進的自動化、數位技術和目標驅動的思維方式的結合代表著模式轉移，其中品質不再是一種可選屬性，而是一項絕對要求。這些全行業的轉型趨勢為更永續的製造方法奠定了基礎，並確保研究和生產能夠跟上快速成長的市場需求。

關鍵市場區隔洞察

透過分析關鍵細分參數，可以增強對 GMP 級細胞培養基市場的整體了解，每個細分參數都可以提供有關市場動態和成長潛力的獨特見解。從產品成分來看，市場正在對胺基酸、生長因子、荷爾蒙、微量元素和維生素進行深入探索。這種分類強調了內源性補充劑對於促進培養系統中細胞健康和生產力的重要性。它還強調了每個成分所起的微妙作用，使得培養基配方能夠精確客製化，以滿足不同細胞株的特定營養需求。

就產品類型而言，市場格局是化學定義的、經典的、無蛋白質的、無血清的和特殊培養基的混合。每種分類都提供了一組獨特的優勢，可以滿足不同的應用需求和操作工作流程。例如，化學成分明確的培養基具有無與倫比的一致性和降低的可變性，而特種培養基則可以針對標準配方不足的複雜應用進行客製化。這種多樣化的選擇不僅提供了靈活性，而且還凸顯了市場對標準和客製化要求的應對力。

此外，根據細胞培養類型的細分可區分連續細胞培養、初代細胞培養和繼發細胞培養。這種分類對於了解各種研究和生產設施所採用的操作技術和擴大規模策略至關重要。雖然連續細胞培養通常與長期、可擴展的生產相關，但初級和二級研究為更精細的早期研究和客製化應用提供了見解。

基於細胞類型的分割透過評估禽細胞、細菌細胞、昆蟲細胞、哺乳動物細胞和酵母進一步縮小視野。每種細胞類型與其培養環境的相互作用不同，因此需要選擇特定的成分和支持系統。例如，哺乳動物細胞培養對於重組蛋白的生產和治療方法開發至關重要，對培養基成分和法規遵循有嚴格的要求。相較之下，細菌和酵母培養物需要支持快速生長和擴充性的配方。

深入研究應用，市場細分為生物製藥生產、研發及組織工程。生物製藥生產進一步細分為單株抗體生產、重組蛋白生產等領域。這些部分反映了治療性蛋白質製造所需的日益複雜的程度和高標準。同時，研發領域進一步細分為 CRISPR 技術、基因治療和幹細胞研究，基因編輯擴展到農業改良和治療開發。在組織工程領域，3D 細胞培養和再生醫學等子類別的研究正在取得進一步進展，基於細胞的分析和類器官形成的進展代表著在創建更多生理相關模型方面取得了重大飛躍。每個細分層都錯綜複雜地交織在一起，不僅揭示了市場需求的多樣性，也揭示了不斷發展的創新格局，以全力支持前沿研究和強大的生產實踐。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球慢性病發生率不斷上升
      • 細胞疫苗的細胞培養技術日益湧現
      • 嚴格的監管標準要求使用高品質的 GMP 級培養基進行藥物開發
    • 限制因素
      • GMP 級細胞培養基的複雜品管要求
    • 機會
      • 個人化醫療趨勢推動成長
      • 擴大GMP級細胞培養基在再生醫學和細胞治療的應用
    • 任務
      • 使用動物性來源產品的倫理問題
  • 市場區隔分析
    • 成分：維生素因其在維持細胞完整性和身體功能方面發揮的重要作用而變得越來越受歡迎。
    • 應用：擴大 GMP 級細胞培養基在組織工程的應用
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會的
    • 技術的
    • 合法的
    • 環境

6. GMP 級細胞培養基市場（依成分）

  • 胺基酸
  • 生長因子
  • 荷爾蒙
  • 微量元素
  • 維他命

第 7 章 GMP 級細胞培養基市場（依產品類型）

  • 化學成分明確的培養基
  • 古典媒體
  • 無蛋白培養基
  • 無血清培養基
  • 專業媒體

8. GMP 級細胞培養基市場（依細胞培養類型）

  • 連續細胞培養
  • 初代細胞培養
  • 二次細胞培養

9. GMP 級細胞培養基市場（依細胞類型）

  • 禽類細胞
  • 細菌細胞
  • 昆蟲細胞
  • 哺乳動物細胞
  • 酵母菌

第 10 章 GMP 級細胞培養基市場（依應用）

  • 生物製藥製造
    • 單株抗體生產
    • 重組蛋白生產
  • 研究與開發
    • CRISPR 技術
      • 基因編輯
      • 農業改良
      • 治療進展
    • 基因治療
    • 幹細胞研究
  • 組織工程
    • 3D 細胞培養
      • 基於細胞的檢測
      • 類器官形成
    • 再生醫學

第 11 章：美洲 GMP 級細胞培養基市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區 GMP 級細胞培養基市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲 GMP 級細胞培養基市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BioLife Solutions Inc.
  • CellGenix GmbH
  • Cook Group Incorporated
  • Corning Incorporated
  • Danaher Corporation
  • DWK Life Sciences GmbH
  • Eppendorf AG
  • Fujifilm Irvine Scientific
  • Gemini Bio-Products, Inc.
  • HiMedia Laboratories Pvt. Ltd
  • InVitria
  • Lonza Group
  • Merck KGaA
  • Miltenyi Biotec
  • MP Biomedicals
  • PromoCell GmbH
  • Sartorius AG
  • STEMCELL Technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FD889

The GMP Grade Cell Culture Media Market was valued at USD 7.93 billion in 2024 and is projected to grow to USD 8.71 billion in 2025, with a CAGR of 9.99%, reaching USD 14.06 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.93 billion
Estimated Year [2025] USD 8.71 billion
Forecast Year [2030] USD 14.06 billion
CAGR (%) 9.99%

GMP grade cell culture media represent a cornerstone in the advancement of biopharmaceutical development and scientific research. In today's rapidly evolving biotech environment, stringent quality standards and adherence to regulatory requirements have elevated the role of these high-grade media. With the increasing need for consistency in product manufacturing and the subsequent impact on overall process reliability, stakeholders have recognized GMP grade media as a critical factor in ensuring both safety and performance outcomes.

The journey toward achieving these standards is not merely about meeting regulatory checklists but involves a continuous interplay of research innovation, process optimization, and robust quality management. Over the past decade, investments in advanced formulations and technology innovations have helped drive the evolution of GMP grade media. This introduction sets the stage for a comprehensive analysis of the market trends and critical segmentation insights that are directly influencing market dynamics. With an emphasis on the critical role of media quality, the narrative explains how these products have become an integral part of modern bioprocessing disciplines, helping reduce variability and enhancing reproducibility across diverse applications.

The significance of high-grade cell culture media is also reflected in the streamlined protocols for tissue engineering, gene therapy, and recombinant protein production. By setting industry benchmarks, these media not only ensure compliance with international quality standards but also facilitate cutting-edge research that propels the entire industry forward.

Furthermore, as companies continue to optimize their production processes, strategic investments in GMP grade media have become a vital aspect of research and development efforts. This introduction provides a clear context for the multifaceted evolution of the market, highlighting the inherent connections between regulatory frameworks, technological innovations, and market demand dynamics within the sphere of cell culture applications.

Transformative Shifts in the Landscape

The cell culture media landscape has experienced transformative shifts fuelled by rapid advancements in biotechnology, regulatory revisions, and a global focus on innovation. In recent years, the integration of emerging technologies and the evolution of scientific protocols have redefined industry norms. Improvements in process automation, enhanced analytics, and tighter integration of real-time monitoring systems have all contributed to more streamlined operations and higher reproducibility in cell culture processes.

Notably, as regulatory bodies refine guidelines to further ensure product safety and efficacy, manufacturers have had to recalibrate their production methods. These shifts have spurred the development of next-generation, GMP grade cell culture media that cater to the evolving needs of both large-scale biopharmaceutical production and intricate research applications. The emphasis on quality and consistency has driven companies to invest in research, resulting in media formulations tailored for a variety of cell types and applications.

In addition, global collaborations and partnerships have encouraged technology transfer and standardization across production facilities. As a result, even regions that previously lagged in adopting state-of-the-art cell culture practices are rapidly catching up. The transformation is evidenced not only in product innovation but also in the way process data is generated, analyzed, and utilized to drive continuous improvement. Modern manufacturing technologies are now promoting a more dynamic, outcome-oriented approach to challenges, aligning technological capabilities with the high expectations of today's market patients.

The convergence of advanced automation, digital technologies, and a purpose-driven mindset signifies a paradigm shift where quality is no longer an optional attribute but an absolute requirement. These industry-wide transformative trends are laying the groundwork for more sustainable manufacturing practices and ensuring that research and production keep pace with the rapid expansion of market needs.

Key Segmentation Insights for the Market

A holistic understanding of the GMP grade cell culture media market is enhanced by dissecting key segmentation parameters, each offering unique insights into market dynamics and growth potential. When looking at product components, the market is diligently studied across amino acids, growth factors, hormones, trace elements, and vitamins. This classification underlines the importance of intrinsic supplements that drive cell health and productivity in culture systems. It also highlights the nuanced role each component plays in ensuring that media formulations can be precisely tailored to meet the specific nutritional needs of various cell lines.

In the context of product type, the market landscape includes a blend of chemically defined media, classical media, protein-free media, serum-free media, and specialty media. Each of these classifications presents a distinct set of benefits, catering to diverse application demands and operational workflows. For instance, chemically defined media offer unparalleled consistency and reduced variability, while specialty media are customized for complex applications where standard formulations may fall short. This spectrum of options not only provides flexibility but also underscores the market's responsiveness to both standard and bespoke requirements.

Furthermore, segmentation based on cell culture type distinguishes between continuous cell culture, primary cell culture, and secondary cell culture. This categorization is essential in understanding the operational methodologies and scale-up strategies adopted by various research and production facilities. Continuous cell culture is often associated with long-term, scalable production, while primary and secondary cultures provide insight into more delicate, early-stage research and bespoke applications.

The segmentation based on cell type further refines our view by evaluating avian cells, bacterial cells, insect cells, mammalian cells, and yeast. Each cell type interacts differently with the media environment, thereby dictating the selection of specific components and supporting systems. For example, mammalian cell cultures, which are critical for recombinant protein production and therapeutic development, impose stringent requirements on media composition and regulatory compliance. In contrast, bacterial and yeast cultures demand formulations that support rapid growth and scalability.

Delving deeper into applications, the market is classified into biopharmaceutical production, research and development, and tissue engineering. Biopharmaceutical production is further subdivided into areas such as monoclonal antibodies production and recombinant proteins production. These segments reflect the increasing complexity and high standards required in therapeutic protein manufacturing. In parallel, the research and development segment is further refined into CRISPR technology, gene therapy, and stem cell research, with gene editing expanding across agricultural modification and therapeutic development. Tissue engineering sees further study in subcategories such as 3D cell culture and regenerative medicine, where the progression to cell-based assays and organoid formation illustrates a significant leap forward in creating more physiologically relevant models. Each segmentation layer interplays intricately to reveal not only the diversity of market demands but also the innovative landscape, which is evolving to support cutting-edge research and robust production methodologies across the board.

Based on Component, market is studied across Amino Acids, Growth Factors, Hormones, Trace Elements, and Vitamins.

Based on Product Type, market is studied across Chemically Defined Media, Classical Media, Protein-Free Media, Serum-Free Media, and Specialty Media.

Based on Cell Culture Type, market is studied across Continuous Cell Culture, Primary Cell Culture, and Secondary Cell Culture.

Based on Cell Type, market is studied across Avian Cells, Bacterial Cells, Insect Cells, Mammalian Cells, and Yeast.

Based on Application, market is studied across Biopharmaceutical Production, Research and Development, and Tissue Engineering. The Biopharmaceutical Production is further studied across Monoclonal Antibodies Production and Recombinant Proteins Production. The Research and Development is further studied across CRISPR Technology, Gene Therapy, and Stem Cell Research. The CRISPR Technology is further studied across Gene Editing. The Gene Editing is further studied across Agricultural Modification and Therapeutic Development. The Tissue Engineering is further studied across 3D Cell Culture and Regenerative Medicine. The 3D Cell Culture is further studied across Cell-Based Assay and Organoid Formation.

Key Regional Insights into Market Dynamics

When evaluating the global spread of GMP grade cell culture media, it is critical to assess regional variances that drive market expansion and innovation. In the Americas, strong investments in biopharmaceutical infrastructure and a legacy of research excellence offer a robust marketplace characterized by growing demands for advanced cell culture solutions and scalable production methods. These trends are largely propelled by the region's well-established network of research institutes and manufacturing facilities.

Across Europe, the Middle East and Africa, regulatory standards and the high emphasis on quality assurance have set the stage for rapid adaptations in cell culture media. In these regions, consistent public and private investments in biotechnology have paved the way for increased market penetration and adoption of novel media formulations that meet stringent quality criteria. These dynamics are supported by a mature ecosystem of research collaborations and a solid regulatory framework.

In Asia-Pacific, rapid industrialization accompanied by significant government initiatives to foster biotechnology innovation has resulted in this region emerging as a key hub for both research and production. The combination of rising healthcare demands, strategic collaborations, and increased public funding has contributed to the acceleration of GMP grade media adoption. This region displays a unique blend of traditional research practices and modern technological integration, making it a vibrant and rapidly evolving segment of the global market. Regional insights across these areas indicate that despite varied economic and regulatory landscapes, market leaders are focusing on quality improvement and innovation to address the diverse needs of their clientele.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Comprehensive Company Insights in the Industry

The picture of market competitiveness becomes clearer when one considers the influence of leading companies in the realm of GMP grade cell culture media. Industry frontrunners such as Avantor, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, and BioLife Solutions Inc. have been instrumental in setting high benchmarks for product quality and operational integrity. The innovation landscape is further enriched by key players including CellGenix GmbH, Cook Group Incorporated, Corning Incorporated, Danaher Corporation, and DWK Life Sciences GmbH. These organizations have combined extensive research experience with state-of-the-art manufacturing processes to deliver products that meet rigorous international quality standards.

Additional market leaders such as Eppendorf AG, Fujifilm Irvine Scientific, and Gemini Bio-Products, Inc. continue to drive growth through strategic approaches that emphasize research collaboration and technological advancement. Their contributions, along with the pioneering work of HiMedia Laboratories Pvt. Ltd, InVitria, Lonza Group, Merck KGaA, and Miltenyi Biotec, highlight a competitive environment where innovation is directly linked to market performance. MP Biomedicals, PromoCell GmbH, Sartorius AG, STEMCELL Technologies, Takara Bio Inc., and Thermo Fisher Scientific Inc. also play crucial roles in shaping the landscape, reinforcing the industry's commitment to continuous improvement and global excellence. These companies, working in tandem with multidimensional research strategies, have catalyzed significant advancements in overall product quality and performance, thus laying the foundation for sustainable growth across the sector.

The report delves into recent significant developments in the GMP Grade Cell Culture Media Market, highlighting leading vendors and their innovative profiles. These include Avantor, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, BioLife Solutions Inc., CellGenix GmbH, Cook Group Incorporated, Corning Incorporated, Danaher Corporation, DWK Life Sciences GmbH, Eppendorf AG, Fujifilm Irvine Scientific, Gemini Bio-Products, Inc., HiMedia Laboratories Pvt. Ltd, InVitria, Lonza Group, Merck KGaA, Miltenyi Biotec, MP Biomedicals, PromoCell GmbH, Sartorius AG, STEMCELL Technologies, Takara Bio Inc., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

In a rapidly evolving market where quality and innovation are constant imperatives, industry leaders are encouraged to adopt a multi-pronged approach to safeguard their competitive advantage. First and foremost, it is essential to invest in state-of-the-art research and development initiatives that are directly aligned with evolving regulatory demands and technological improvements. Embracing digital transformation, including automation and data analytics, can further enhance operational efficiencies and product consistency.

Moreover, fostering strategic collaborations with research institutions, biotech companies, and regulatory bodies can serve to streamline product development and ensure compliance with international standards. Leaders should also consider diversifying their product portfolios to include a balanced mix of chemically defined and specialty media. This not only mitigates risks associated with market volatility but also positions organizations to meet a range of client-specific needs.

Additionally, continuous training and upskilling of workforce capabilities in advanced bioprocessing techniques will be crucial. With the market becoming increasingly sophisticated, enhancing internal competencies through regular knowledge exchanges and technology workshops will facilitate the adoption of next-generation media formulations and quality control measures.

Investing in robust supply chain management systems and ensuring transparency in sourcing raw materials can further reinforce the integrity of product quality. Adapting customer-centric approaches by engaging with end-users and incorporating their feedback into product development will help in tailoring solutions that offer maximum efficacy and reliability. By seamlessly integrating these strategies, industry leaders can not only boost their market competitiveness but also contribute to setting new quality standards across the board.

Conclusion: A Transformative Era in Cell Culture Media

The evolution of GMP grade cell culture media encapsulates a transformative era defined by scientific innovation, stringent quality standards, and proactive regulatory frameworks. From foundational research to large-scale biopharmaceutical manufacturing, these media have become indispensable in driving advancements across multiple domains of biotechnology. The convergence of strategic investments in research and development, along with emerging technologies, is redefining the landscape, enabling enhanced product consistency and broadening application scopes.

The multi-dimensional segmentation-from fundamental components and product types to varied cell culture methodologies and regional market dynamics-offers a detailed perspective on how diverse market segments are interlinked and mutually reinforcing. Furthermore, the active roles played by leading companies in advancing technology, streamlining processes, and meeting demanding regulatory requirements underscore the synergistic efforts propelling industry growth.

In summary, the trajectory of GMP grade cell culture media is emblematic of a sector that is continually adapting to meet the demands of precision, efficiency, and quality. As the market progresses, stakeholders are presented with unprecedented opportunities for innovation and improvement, ensuring that the industry remains dynamic and responsive to future challenges.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases globally
      • 5.1.1.2. Growing emergence of cell culture technologies for cell-based vaccines
      • 5.1.1.3. Stringent regulatory standards mandating use of high-quality GMP grade media for drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Complex quality control requirements in the GMP grade cell culture media
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing trend toward personalized medicine fueling growth
      • 5.1.3.2. Expanding GMP grade cell culture media applications in regenerative medicine and cell therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues concerning the use of animal-derived products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing preference for vitamins due to their essential role in maintaining cellular integrity and functioning of the body
    • 5.2.2. Application: Expanding application of GMP grade cell culture media in tissue engineering
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. GMP Grade Cell Culture Media Market, by Component

  • 6.1. Introduction
  • 6.2. Amino Acids
  • 6.3. Growth Factors
  • 6.4. Hormones
  • 6.5. Trace Elements
  • 6.6. Vitamins

7. GMP Grade Cell Culture Media Market, by Product Type

  • 7.1. Introduction
  • 7.2. Chemically Defined Media
  • 7.3. Classical Media
  • 7.4. Protein-Free Media
  • 7.5. Serum-Free Media
  • 7.6. Specialty Media

8. GMP Grade Cell Culture Media Market, by Cell Culture Type

  • 8.1. Introduction
  • 8.2. Continuous Cell Culture
  • 8.3. Primary Cell Culture
  • 8.4. Secondary Cell Culture

9. GMP Grade Cell Culture Media Market, by Cell Type

  • 9.1. Introduction
  • 9.2. Avian Cells
  • 9.3. Bacterial Cells
  • 9.4. Insect Cells
  • 9.5. Mammalian Cells
  • 9.6. Yeast

10. GMP Grade Cell Culture Media Market, by Application

  • 10.1. Introduction
  • 10.2. Biopharmaceutical Production
    • 10.2.1. Monoclonal Antibodies Production
    • 10.2.2. Recombinant Proteins Production
  • 10.3. Research and Development
    • 10.3.1. CRISPR Technology
      • 10.3.1.1. Gene Editing
      • 10.3.1.1.1. Agricultural Modification
      • 10.3.1.1.2. Therapeutic Development
    • 10.3.2. Gene Therapy
    • 10.3.3. Stem Cell Research
  • 10.4. Tissue Engineering
    • 10.4.1. 3D Cell Culture
      • 10.4.1.1. Cell-Based Assay
      • 10.4.1.2. Organoid Formation
    • 10.4.2. Regenerative Medicine

11. Americas GMP Grade Cell Culture Media Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific GMP Grade Cell Culture Media Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa GMP Grade Cell Culture Media Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. SEKISUI Diagnostics completed a pound 15.7 million expansion at its UK site
    • 14.3.2. REPROCELL USA inaugurated a GMP manufacturing facility in Maryland, enhancing its capabilities in producing hiPSC and hMSC
    • 14.3.3. BASF Pharma Solutions introduces Kolliphor P188 Cell Culture to enhance cell viability and density
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Avantor, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Techne Corporation
  • 4. BioLife Solutions Inc.
  • 5. CellGenix GmbH
  • 6. Cook Group Incorporated
  • 7. Corning Incorporated
  • 8. Danaher Corporation
  • 9. DWK Life Sciences GmbH
  • 10. Eppendorf AG
  • 11. Fujifilm Irvine Scientific
  • 12. Gemini Bio-Products, Inc.
  • 13. HiMedia Laboratories Pvt. Ltd
  • 14. InVitria
  • 15. Lonza Group
  • 16. Merck KGaA
  • 17. Miltenyi Biotec
  • 18. MP Biomedicals
  • 19. PromoCell GmbH
  • 20. Sartorius AG
  • 21. STEMCELL Technologies
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GMP GRADE CELL CULTURE MEDIA MARKET MULTI-CURRENCY
  • FIGURE 2. GMP GRADE CELL CULTURE MEDIA MARKET MULTI-LANGUAGE
  • FIGURE 3. GMP GRADE CELL CULTURE MEDIA MARKET RESEARCH PROCESS
  • FIGURE 4. GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. GMP GRADE CELL CULTURE MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. GMP GRADE CELL CULTURE MEDIA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GMP GRADE CELL CULTURE MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GMP GRADE CELL CULTURE MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CLASSICAL MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PROTEIN-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CONTINUOUS CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRIMARY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SECONDARY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AVIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AGRICULTURAL MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY ORGANOID FORMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 303. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 304. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND GMP GRA